Crossmark

Synthesis and Biological Evaluation of Novel 1,2,3-Triazole Based Pyrido[4,3-d]pyrimidines as Potent Anticancer and EGFR Inhibitors

Published Online: 2022-01-17

Published Print: 2021-12

Authors

Sreerama, Rakesh

Kumar, N. Manoj

Nukala, Satheesh Kumar

Sucharitha, E. Ramya

Babu, H. Ramesh

Narsimha, Sirassu
License Information

Text and Data Mining valid from 2021-12-01

Version of Record valid from 2021-12-01
More Information

Article History

Received: 9 November 2021

Revised: 1 December 2021

Accepted: 6 December 2021

First Online: 17 January 2022

CONFLICT OF INTEREST

: No conflict of interest was declared by the authors.

Document is current